Multiparameter flow cytometry for the diagnosis and monitoring of small GPI‐deficient cellular populations M Battiwalla, M Hepgur, D Pan, PL McCarthy, MS Ahluwalia, ... Cytometry Part B: Clinical Cytometry 78 (5), 348-356, 2010 | 34 | 2010 |
Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation M Hepgur, MS Ahluwalia, N Anne, J Thomas, H Liu, MD Schiff, PA Loud, ... Bone marrow transplantation 46 (6), 876-879, 2011 | 32 | 2011 |
Tivozanib in the treatment of renal cell carcinoma M Hepgur, S Sadeghi, TB Dorff, DI Quinn Biologics: Targets and Therapy, 139-148, 2013 | 30 | 2013 |
Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1–3 and complement factor H 479 P Chaudhary, M Hepgur, S Sarkissian, RJH Smith, IC Weitz Blood Transfusion 12 (1), 111, 2014 | 10 | 2014 |
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal TB Dorff, C Wilkins, M Hepgur, DI Quinn Clinical genitourinary cancer 12 (2), e55-e58, 2014 | 3 | 2014 |
Changes in circulating tumor cells (CTC) and markers of inflammation after sipuleucel-T treatment. M Hepgur, TB Dorff, J Cai, JK Pinski, M Reed, M Luther, B Chan, DI Quinn Journal of Clinical Oncology 31 (6_suppl), 40-40, 2013 | 1 | 2013 |
Atypical presentation of vaginal GvHD with abdominal pain crises MG Hepgur, P Paplham, A Ghomi, C Vyas, PL McCarthy, S Smiley, ... Biology of Blood and Marrow Transplantation 16 (2), S315, 2010 | 1 | 2010 |
Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC). DIQ Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan J Clin Oncol 33 (suppl 7), abstr 181, 2015 | | 2015 |
Identification of biologic and inflammatory markers for predicting clinical responses to sipuleucel-T in CRPC. MF Hepgur, TB Dorff, L Brining, J Cai, JK Pinski, M Reed, M Luther, ... Journal of Clinical Oncology 32 (4_suppl), 134-134, 2014 | | 2014 |
Clinical and biologic factors for immune response to sipuleucel-T (SipT) for metastatic castrate-resistant prostate cancer (mCRPC). MF Hepgur, TB Dorff, L Brining, J Cai, JK Pinski, M Reed, M Luther, ... Journal of Clinical Oncology 32 (4_suppl), 219-219, 2014 | | 2014 |
A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome MF Hepgur, P Chaudhary, S Sarkissian, RJH Smith, H Liebman, IC Weitz Blood 120 (21), 4644, 2012 | | 2012 |
Early Complete Donor Lymphoid Chimerism With Fludarabine, Melphalan And Low Dose (400 CGy) Total Body Irradiation Reduced Intensity Conditioning M Hepgur, N Saito, T Hahn, P Starostik, P Wallace, B Bambach, ... Biology of Blood and Marrow Transplantation 16 (2), S291-S292, 2010 | | 2010 |
Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the Lung Hepgur M International Journal of Hematology and Oncology 20 (4), 241-244, 2010 | | 2010 |